Clustering of genomic inv(16)(p13q22) breakpoints in acute nonlymphocytic leukemia

被引：0
|
作者：
vanderReijden, BA [1 ]
Wijmenga, C [1 ]
Liu, P [1 ]
Dauwerse, JG [1 ]
Giles, RH [1 ]
Changur, S [1 ]
vanOmmen, GJ [1 ]
Hagemeijer, A [1 ]
Breuning, M [1 ]
机构：
[1] LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2968 / 2968
页数：1
相关论文
共 50 条
  • [21] Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report
    Onate, Guadalupe
    Laura Blanco, Maria
    Pratcorona, Marta
    MEDICINA CLINICA, 2019, 152 (10): : 419 - 420
  • [22] Nuclear factor kappa B is overexpressed in acute myeloid leukemia with inv(16)(p13q22) compared with acute myelomonocytic leukemia (M4) without inv16
    Konoplev, S.
    Sun, X.
    Kantarjian, H. M.
    Estey, E. H.
    Medeiros, L. J.
    Bueso-Ramos, C. E.
    LABORATORY INVESTIGATION, 2007, 87 : 248A - 249A
  • [23] Nuclear factor kappa B is overexpressed in acute myeloid leukemia with inv(16)(p13q22) compared with acute myelomonocytic leukemia (M4) without inv16
    Konoplev, S.
    Sun, X.
    Kantarjian, H. M.
    Estey, E. H.
    Medeiros, L. J.
    Bueso-Ramos, C. E.
    MODERN PATHOLOGY, 2007, 20 : 248A - 249A
  • [24] The prognostic significance of 3′ CBFB deletions in inv(16)(p13q22)/t(16;16)(p13;q22)
    Huxley, E
    Griffiths, MJ
    Talley, P
    Whitworth, A
    Humphreys, M
    McKinley, M
    JOURNAL OF MEDICAL GENETICS, 2005, 42 : S81 - S81
  • [25] RT-PCR DIAGNOSIS OF PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AND INV(16)(P13Q22) AND IDENTIFICATION OF NEW ALTERNATIVE SPLICING IN CBFB-MYH11 TRANSCRIPTS
    VANDERREIJDEN, BA
    LOMBARDO, M
    DAUWERSE, HG
    GILES, RH
    MUHLEMATTER, D
    BELLOMO, MJ
    WESSELS, HW
    BEVERSTOCK, GC
    VANOMMEN, GJB
    HAGEMEIJER, A
    BREUNING, MH
    BLOOD, 1995, 86 (01) : 277 - 282
  • [26] Unique signaling pathways in acute myeloid leukemia with inv(16)(p13q22) revealed by gene expression profiling.
    Sun, XP
    Medeiros, LJ
    Zhang, W
    Ramdas, L
    Glassman, AB
    Taylor, E
    Jones, D
    Estey, EH
    Buesco-Ramos, CE
    BLOOD, 2003, 102 (11) : 377A - 377A
  • [27] DO LEUKEMIA PATIENTS WITH CHROMOSOME-16 INVERSION INV(16)(P13Q22) HAVE A RARE FRAGILE SITE AT 16Q22
    OHYASHIKI, K
    OHYASHIKI, JH
    TOYAMA, K
    ITO, H
    CANCER GENETICS AND CYTOGENETICS, 1988, 31 (01) : 31 - 34
  • [28] Inv(16)(p13q22) in chronic myelogenous leukemia: Clinical, morphologic and cytogenetic study of five cases
    Merzianu, M
    Lin, P
    Glassman, A
    Hayes, K
    Huh, Y
    MODERN PATHOLOGY, 2005, 18 : 241A - 242A
  • [29] Detection of inv(16)(p13q22) by means of chromosome painting with a 16q-specific probe
    Li, M
    Xue, YQ
    Wu, YF
    Pan, JL
    CANCER GENETICS AND CYTOGENETICS, 2004, 150 (01) : 86 - 87
  • [30] ACUTE MYELOMONOCYTIC LEUKEMIA WITH MARROW EOSINOPHILIA (M4EO) AND INV(16)(P13Q22) IN A PATIENT WITH A HERITABLE FRAGILE SITE 16Q22
    ARTHUR, DC
    AASENG, SM
    BLOOMFIELD, CD
    CYTOGENETICS AND CELL GENETICS, 1985, 40 (1-4): : 572 - 572
12345